Lupus conference? I have read that announcement. It's great.
But NOX are acting like kids in a chemistry lab. No sense of urgency and no awareness of current market conditions.
Have a play with COVID. Have a play with inflammation. With pancreatic cancer. With Lupus. With mRNA vaccines.
None of these plays with a near term viable commercial strategy.
All the while, basically ignoring the only asset that has a snowballs chance in hell of funding their pipeline.
Ann: Noxopharm Announces Novel mRNA Vaccine Enhancer, page-14
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.5¢ | $1.863K | 16.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 103413 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 159073 | 5 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |